title: A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.
authors.affiliation: Department of Dermatology, Mount Sinai School of Medicine, New York, NY, USA.
authors.forename: M
authors.initials: M
authors.lastname: Lebwohl
authors.forename: S B
authors.initials: SB
authors.lastname: Siskin
authors.forename: W
authors.initials: W
authors.lastname: Epinette
authors.forename: D
authors.initials: D
authors.lastname: Breneman
authors.forename: T
authors.initials: T
authors.lastname: Funicella
authors.forename: R
authors.initials: R
authors.lastname: Kalb
authors.forename: J
authors.initials: J
authors.lastname: Moore
mesh_terms: D000279:Administration, Cutaneous; D000328:Adult; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002990:Clobetasol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy*; D012074:Remission Induction; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D003879:Dermatologic Agents; D004338:Drug Combinations; D009824:Ointments; D014662:Vasoconstrictor Agents; C055085:calcipotriene; C064466:halobetasol; D002990:Clobetasol; D002117:Calcitriol